As the global economy mends, the 2021 growth of Chlorpheniramine Maleate will have significant change from previous year. According to our (LP Information) latest study, the global Chlorpheniramine Maleate market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Chlorpheniramine Maleate market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Chlorpheniramine Maleate market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Chlorpheniramine Maleate market, reaching US$ million by the year 2028. As for the Europe Chlorpheniramine Maleate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Chlorpheniramine Maleate players cover AstraZeneca, Beijing Pacific Pharmaceutical, Gedeon Richter, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Chlorpheniramine Maleate market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Injection
Syrup
Tablets
Powder
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Allergy
Hay Fever
Common Cold
Itchy Throat/Skin
Rhinitis
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Beijing Pacific Pharmaceutical
Gedeon Richter
GlaxoSmithKline
Merck
Renhetang Pharmaceutical
Sanofi
Guangdong Nanguo Pharmaceutical
Henan Jiushi Pharmaceutical
Huarun Shuanghe Pharmaceutical
Huazhong Pharmaceutical
Jilin Bainianhanke Pharmaceutical
Jilin Province Fuertai Pharmaceutical Co. , Ltd
Linfen Baozhu Pharmaceutical
Shaanxi Bikang Pharmaceutical Group Holding Co. , Ltd.
Shanghai Hefeng Pharmaceutical
Shanghai Modern Pharmaceutical
Shanghai Shangyao Xinyi Pharmaceutical
Shanghai Xudong Haiyin Pharmaceutical
Sinopharm Group
Suicheng Pharmaceutical
Tianjin Jinyao group
Wuhu Kangqi Pharmaceutical
Xinxiang Changle Pharmaceutical
Yunnan Botanical Pharmaceutical